Which ETFs hold Vertex Pharmaceuticals Inc (VRTX)?
American biotech company best known for its cystic fibrosis medicines.
46 Australian ETFs hold Vertex Pharmaceuticals Inc, a Health Care company from United States. ESGI has the biggest weighting at 2.54%. Across these funds, Australian ETF investors own about $318m of Vertex Pharmaceuticals Inc.
The ETFs with the most Vertex Pharmaceuticals Inc
All 46 ETFs that hold Vertex Pharmaceuticals Inc, ranked by weight
Best-endeavours estimate. Built from each issuer's published holdings, which may be weeks or months old, may cover only part of a fund (some publish only their top 10) and are matched by company name. Figures may be incomplete or inaccurate. Check the issuer's website and PDS before relying on them. General information only.
Weights from each issuer's published holdings (September to November 2026). Some funds list only their largest holdings. General information only, not a recommendation to buy or sell Vertex Pharmaceuticals Inc.
Common questions
Which ETF has the most Vertex Pharmaceuticals Inc?
ESGI (VanEck MSCI International Sustainable Equity ETF) has the highest weighting, with 2.54% of the fund in Vertex Pharmaceuticals Inc.
What is the cheapest ETF that holds Vertex Pharmaceuticals Inc?
Of the ETFs where Vertex Pharmaceuticals Inc is at least 1% of the fund, QLTY has the lowest fee at 0.35% a year, with 1.29% in Vertex Pharmaceuticals Inc.
How much Vertex Pharmaceuticals Inc do I own with $10,000 in VGS?
About $15. VGS is the largest ETF that holds Vertex Pharmaceuticals Inc, and Vertex Pharmaceuticals Inc makes up 0.15% of it.
How many Australian ETFs hold Vertex Pharmaceuticals Inc?
46 ETFs listed on the ASX or TMX Australia hold Vertex Pharmaceuticals Inc, based on issuers' published holdings.